ER
IDXX icon

Enlightenment Research’s Idexx Laboratories IDXX Stock Holding History

Enlightenment Research’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-900
Closed -$316K – 123
2022
Q2 		$316K Buy
+900
New +$367K 0.68% 58

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Enlightenment Research's IDXX Position: Q3 2022 in Review

Enlightenment Research sold out of Idexx Laboratories (IDXX) in Q3 2022, closing a stake of 900 shares — an estimated $316K sold.

Enlightenment Research first reported a position in IDXX in Q2 2022 and held it in 1 quarter. The position peaked at $316K in Q2 2022. 925 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

  • Enlightenment Research reported no remaining Idexx Laboratories position as of Q3 2022 after selling out during the quarter.
  • Enlightenment Research sold 900 Idexx Laboratories shares in Q3 2022, an estimated $316K.
  • Enlightenment Research first reported a position in Idexx Laboratories in Q2 2022 and held it in 1 quarter.
  • Enlightenment Research's Idexx Laboratories position peaked at $316K in Q2 2022.
  • 925 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Enlightenment Research's 13F filing for Q3 2022, filed 15 Nov 2022.